Global Silk Fibroin Biomaterials Market Growth 2025-2031

Publication ID:

LPI03256915

Publication Date:

March 27, 2025

Pages:

120

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Manufacturing (Chemicals) [2]

Chemicals [3]

Description:

The global Silk Fibroin Biomaterials market size is predicted to grow from US$ 2.9 million in 2025 to US$ 4 million in 2031; it is expected to grow at a CAGR of 5.6% from 2025 to 2031.
Silk fibroin biomaterials are derived from silk, a natural protein fiber produced by silkworms. Fibroin, the primary structural protein of silk, is biocompatible, biodegradable, and possesses remarkable mechanical properties, including high tensile strength and elasticity. This makes it suitable for diverse biomedical applications. Silk fibroin can be processed into various forms like films, scaffolds, hydrogels, and nanoparticles. These materials are utilized in tissue engineering, drug delivery, wound healing, and biosensors due to their ability to support cell adhesion, proliferation, and differentiation, promoting tissue regeneration and controlled release of therapeutic agents.
The silk fibroin biomaterials industry is experiencing significant growth driven by the increasing demand for natural, biocompatible, and biodegradable materials in various biomedical applications. Several key trends are shaping the industry. Firstly, there's a strong focus on developing advanced silk fibroin scaffolds for tissue engineering and regenerative medicine, particularly for bone, cartilage, and skin regeneration. Researchers are exploring novel fabrication techniques like 3D printing, electrospinning, and freeze-drying to create complex and porous scaffolds that mimic the native extracellular matrix. Secondly, the use of silk fibroin in drug delivery systems is expanding rapidly. Its ability to encapsulate and release drugs, proteins, and other therapeutic agents in a controlled and sustained manner is being exploited for targeted therapies and personalized medicine. Another prominent trend is the development of silk fibroin-based wound dressings and skin substitutes. Its biocompatibility, biodegradability, and ability to promote cell proliferation and collagen synthesis make it an ideal material for promoting wound healing and reducing scarring. Furthermore, there's a growing emphasis on surface modification and functionalization of silk fibroin to enhance its bioactivity and tailor its properties for specific applications. This includes incorporating growth factors, peptides, and other bioactive molecules to improve cell interactions and tissue integration. Finally, sustainable sourcing and processing of silk fibroin are becoming increasingly important, with a focus on environmentally friendly extraction and purification methods. These trends collectively point towards a promising future for silk fibroin biomaterials in various biomedical fields, contributing to advancements in regenerative medicine, drug delivery, and wound care.
The 鈥淪ilk Fibroin Biomaterials Industry Forecast鈥� looks at past sales and reviews total world Silk Fibroin Biomaterials sales in 2024, providing a comprehensive analysis by region and market sector of projected Silk Fibroin Biomaterials sales for 2025 through 2031. With Silk Fibroin Biomaterials sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Silk Fibroin Biomaterials industry.
This Insight Report provides a comprehensive analysis of the global Silk Fibroin Biomaterials landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Silk Fibroin Biomaterials portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Silk Fibroin Biomaterials market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Silk Fibroin Biomaterials and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Silk Fibroin Biomaterials.
This report presents a comprehensive overview, market shares, and growth opportunities of Silk Fibroin Biomaterials market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Silk Fibroin Powder
Silk Amino Acids
Silk Peptide
Segmentation by Application:
Cosmetic & Personal Care
Biomedical
Supplements
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Sofregen Inc
Cocoon Biotech
CPT Sutures
Kelisema Srl
Seidecosa
SEIREN
Hanzhou Linran
Huzhou Xintiansi Bio-tech
Chongqing Haifan Biochemical
Suzhou Suhao Bio
Zhejiang Xingyue Biotechnology
Cathaya
Key Questions Addressed in this Report
What is the 10-year outlook for the global Silk Fibroin Biomaterials market?
What factors are driving Silk Fibroin Biomaterials market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Silk Fibroin Biomaterials market opportunities vary by end market size?
How does Silk Fibroin Biomaterials break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Silk Fibroin Biomaterials Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Silk Fibroin Biomaterials by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Silk Fibroin Biomaterials by Country/Region, 2020, 2024 & 2031
2.2 Silk Fibroin Biomaterials Segment by Type
2.2.1 Silk Fibroin Powder
2.2.2 Silk Amino Acids
2.2.3 Silk Peptide
2.3 Silk Fibroin Biomaterials Sales by Type
2.3.1 Global Silk Fibroin Biomaterials Sales Market Share by Type (2020-2025)
2.3.2 Global Silk Fibroin Biomaterials Revenue and Market Share by Type (2020-2025)
2.3.3 Global Silk Fibroin Biomaterials Sale Price by Type (2020-2025)
2.4 Silk Fibroin Biomaterials Segment by Application
2.4.1 Cosmetic & Personal Care
2.4.2 Biomedical
2.4.3 Supplements
2.5 Silk Fibroin Biomaterials Sales by Application
2.5.1 Global Silk Fibroin Biomaterials Sale Market Share by Application (2020-2025)
2.5.2 Global Silk Fibroin Biomaterials Revenue and Market Share by Application (2020-2025)
2.5.3 Global Silk Fibroin Biomaterials Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Silk Fibroin Biomaterials Breakdown Data by Company
3.1.1 Global Silk Fibroin Biomaterials Annual Sales by Company (2020-2025)
3.1.2 Global Silk Fibroin Biomaterials Sales Market Share by Company (2020-2025)
3.2 Global Silk Fibroin Biomaterials Annual Revenue by Company (2020-2025)
3.2.1 Global Silk Fibroin Biomaterials Revenue by Company (2020-2025)
3.2.2 Global Silk Fibroin Biomaterials Revenue Market Share by Company (2020-2025)
3.3 Global Silk Fibroin Biomaterials Sale Price by Company
3.4 Key Manufacturers Silk Fibroin Biomaterials Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Silk Fibroin Biomaterials Product Location Distribution
3.4.2 Players Silk Fibroin Biomaterials Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Silk Fibroin Biomaterials by Geographic Region
4.1 World Historic Silk Fibroin Biomaterials Market Size by Geographic Region (2020-2025)
4.1.1 Global Silk Fibroin Biomaterials Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Silk Fibroin Biomaterials Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Silk Fibroin Biomaterials Market Size by Country/Region (2020-2025)
4.2.1 Global Silk Fibroin Biomaterials Annual Sales by Country/Region (2020-2025)
4.2.2 Global Silk Fibroin Biomaterials Annual Revenue by Country/Region (2020-2025)
4.3 Americas Silk Fibroin Biomaterials Sales Growth
4.4 APAC Silk Fibroin Biomaterials Sales Growth
4.5 Europe Silk Fibroin Biomaterials Sales Growth
4.6 Middle East & Africa Silk Fibroin Biomaterials Sales Growth
5 Americas
5.1 Americas Silk Fibroin Biomaterials Sales by Country
5.1.1 Americas Silk Fibroin Biomaterials Sales by Country (2020-2025)
5.1.2 Americas Silk Fibroin Biomaterials Revenue by Country (2020-2025)
5.2 Americas Silk Fibroin Biomaterials Sales by Type (2020-2025)
5.3 Americas Silk Fibroin Biomaterials Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Silk Fibroin Biomaterials Sales by Region
6.1.1 APAC Silk Fibroin Biomaterials Sales by Region (2020-2025)
6.1.2 APAC Silk Fibroin Biomaterials Revenue by Region (2020-2025)
6.2 APAC Silk Fibroin Biomaterials Sales by Type (2020-2025)
6.3 APAC Silk Fibroin Biomaterials Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Silk Fibroin Biomaterials by Country
7.1.1 Europe Silk Fibroin Biomaterials Sales by Country (2020-2025)
7.1.2 Europe Silk Fibroin Biomaterials Revenue by Country (2020-2025)
7.2 Europe Silk Fibroin Biomaterials Sales by Type (2020-2025)
7.3 Europe Silk Fibroin Biomaterials Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Silk Fibroin Biomaterials by Country
8.1.1 Middle East & Africa Silk Fibroin Biomaterials Sales by Country (2020-2025)
8.1.2 Middle East & Africa Silk Fibroin Biomaterials Revenue by Country (2020-2025)
8.2 Middle East & Africa Silk Fibroin Biomaterials Sales by Type (2020-2025)
8.3 Middle East & Africa Silk Fibroin Biomaterials Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Silk Fibroin Biomaterials
10.3 Manufacturing Process Analysis of Silk Fibroin Biomaterials
10.4 Industry Chain Structure of Silk Fibroin Biomaterials
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Silk Fibroin Biomaterials Distributors
11.3 Silk Fibroin Biomaterials Customer
12 World Forecast Review for Silk Fibroin Biomaterials by Geographic Region
12.1 Global Silk Fibroin Biomaterials Market Size Forecast by Region
12.1.1 Global Silk Fibroin Biomaterials Forecast by Region (2026-2031)
12.1.2 Global Silk Fibroin Biomaterials Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Silk Fibroin Biomaterials Forecast by Type (2026-2031)
12.7 Global Silk Fibroin Biomaterials Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Sofregen Inc
13.1.1 Sofregen Inc Company Information
13.1.2 Sofregen Inc Silk Fibroin Biomaterials Product Portfolios and Specifications
13.1.3 Sofregen Inc Silk Fibroin Biomaterials Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Sofregen Inc Main Business Overview
13.1.5 Sofregen Inc Latest Developments
13.2 Cocoon Biotech
13.2.1 Cocoon Biotech Company Information
13.2.2 Cocoon Biotech Silk Fibroin Biomaterials Product Portfolios and Specifications
13.2.3 Cocoon Biotech Silk Fibroin Biomaterials Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Cocoon Biotech Main Business Overview
13.2.5 Cocoon Biotech Latest Developments
13.3 CPT Sutures
13.3.1 CPT Sutures Company Information
13.3.2 CPT Sutures Silk Fibroin Biomaterials Product Portfolios and Specifications
13.3.3 CPT Sutures Silk Fibroin Biomaterials Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 CPT Sutures Main Business Overview
13.3.5 CPT Sutures Latest Developments
13.4 Kelisema Srl
13.4.1 Kelisema Srl Company Information
13.4.2 Kelisema Srl Silk Fibroin Biomaterials Product Portfolios and Specifications
13.4.3 Kelisema Srl Silk Fibroin Biomaterials Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Kelisema Srl Main Business Overview
13.4.5 Kelisema Srl Latest Developments
13.5 Seidecosa
13.5.1 Seidecosa Company Information
13.5.2 Seidecosa Silk Fibroin Biomaterials Product Portfolios and Specifications
13.5.3 Seidecosa Silk Fibroin Biomaterials Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Seidecosa Main Business Overview
13.5.5 Seidecosa Latest Developments
13.6 SEIREN
13.6.1 SEIREN Company Information
13.6.2 SEIREN Silk Fibroin Biomaterials Product Portfolios and Specifications
13.6.3 SEIREN Silk Fibroin Biomaterials Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 SEIREN Main Business Overview
13.6.5 SEIREN Latest Developments
13.7 Hanzhou Linran
13.7.1 Hanzhou Linran Company Information
13.7.2 Hanzhou Linran Silk Fibroin Biomaterials Product Portfolios and Specifications
13.7.3 Hanzhou Linran Silk Fibroin Biomaterials Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Hanzhou Linran Main Business Overview
13.7.5 Hanzhou Linran Latest Developments
13.8 Huzhou Xintiansi Bio-tech
13.8.1 Huzhou Xintiansi Bio-tech Company Information
13.8.2 Huzhou Xintiansi Bio-tech Silk Fibroin Biomaterials Product Portfolios and Specifications
13.8.3 Huzhou Xintiansi Bio-tech Silk Fibroin Biomaterials Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Huzhou Xintiansi Bio-tech Main Business Overview
13.8.5 Huzhou Xintiansi Bio-tech Latest Developments
13.9 Chongqing Haifan Biochemical
13.9.1 Chongqing Haifan Biochemical Company Information
13.9.2 Chongqing Haifan Biochemical Silk Fibroin Biomaterials Product Portfolios and Specifications
13.9.3 Chongqing Haifan Biochemical Silk Fibroin Biomaterials Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Chongqing Haifan Biochemical Main Business Overview
13.9.5 Chongqing Haifan Biochemical Latest Developments
13.10 Suzhou Suhao Bio
13.10.1 Suzhou Suhao Bio Company Information
13.10.2 Suzhou Suhao Bio Silk Fibroin Biomaterials Product Portfolios and Specifications
13.10.3 Suzhou Suhao Bio Silk Fibroin Biomaterials Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Suzhou Suhao Bio Main Business Overview
13.10.5 Suzhou Suhao Bio Latest Developments
13.11 Zhejiang Xingyue Biotechnology
13.11.1 Zhejiang Xingyue Biotechnology Company Information
13.11.2 Zhejiang Xingyue Biotechnology Silk Fibroin Biomaterials Product Portfolios and Specifications
13.11.3 Zhejiang Xingyue Biotechnology Silk Fibroin Biomaterials Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Zhejiang Xingyue Biotechnology Main Business Overview
13.11.5 Zhejiang Xingyue Biotechnology Latest Developments
13.12 Cathaya
13.12.1 Cathaya Company Information
13.12.2 Cathaya Silk Fibroin Biomaterials Product Portfolios and Specifications
13.12.3 Cathaya Silk Fibroin Biomaterials Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Cathaya Main Business Overview
13.12.5 Cathaya Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂